vanadates has been researched along with d-phenylalanyl-cysteinyl-tyrosyl-tryptophyl-lysyl-cysteinyl-threoninamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arano, Y; Doi, R; Fujii, N; Fujimoto, K; Hirohashi, M; Hosotani, R; Imamura, M; Koshiba, T; Lee, JU; Miyamoto, Y; Nakajima, S; Tsuji, S; Uehara, T; Wada, M | 1 |
1 other study(ies) available for vanadates and d-phenylalanyl-cysteinyl-tyrosyl-tryptophyl-lysyl-cysteinyl-threoninamide
| Article | Year |
|---|---|
Antiproliferative activity induced by the somatostatin analogue, TT-232, in human pancreatic cancer cells.
Topics: Antineoplastic Agents; Cell Division; Humans; Pancreatic Neoplasms; Peptides, Cyclic; Phosphorylation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Somatostatin; Tumor Cells, Cultured; Vanadates | 2002 |